Company intelligence / Profile preview

CommonSense

Ownership: Private
Development stage: Other

Overview

Common Sense was founded in 1999 and is a leading developer and manufacturer of indicators utilizing common hygienic products such as panty liners. The company signed an agreement with Duramed Pharmaceuticals, Inc. to develop and market AL-SENSE®, an amniotic fluid detection device.

Therapeutic areas: Women's Health
Modalities: Device
Industry: Metabolite Diagnostics

Partnerships

Duramed Pharmaceuticals, Inc.

Beyond the preview

Go deeper on CommonSense.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CommonSense.

Explore the full profile